News

Press Releases and Publications

Duo Oncology Announces Close of Initial Seed Investment

Duo Oncology is pleased to announce a $1M+ seed investment led by UPMC oncologists Dr. Stanley Marks and Dr. Jing-Zhou Hou.

Duo Oncology Joins LifeX Incubator

LifeX Labs welcomes new portfolio company, Duo Onoclogy, into incubator program.

Duo Oncology Appoints Dr. Stanley Marks to Board of Directors

Duo Oncology is pleased to welcome Dr. Stanley Marks to its board of directors. Dr. Marks is a world renown oncology and chairman of the UPMC Hillman Cancer Center.

Duo Oncology Options Nanoparticle Platform from University of Pittsburgh

Duo Oncology signed an option to exclusively license nanoparticle prodrug chemistry patented developed in the laboratory of Dr. Song Li and patented by the University of Pittsburgh

©2020 by Duo Oncology, Pittsburgh PA.

  • Twitter
  • LinkedIn